m*********y
发帖数: 10616 | | e*n
发帖数: 1511 | 2 Italian Medicines Agency Approves NerPharMa to Manufacture Cell Therapeutics
' Drug Pixantrone in European Union
SEATTLE, June 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (
Nasdaq and MTA: CTIC) today announced that the Italian Medicines Agency ("
AIFA"), the national authority responsible for drug regulation in Italy, has
approved the facility at NerPharMa DS (a pharmaceutical manufacturing
company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for
the production of CTI's drug candidate pixantrone. CTI is in the process of
preparing a Marketing Authorization Application ("MAA") in the European
Union for pixantrone to treat relapsed or refractory aggressive non-Hodgkin'
s lymphoma ("NHL").
"We are pleased that the AIFA has approved the NerPharMa facility to
manufacture pixantrone as we continue to receive positive feedback on the
clinical trial results from leading clinicians in Europe and make progress
in the submission of the MAA in Europe," said Craig W. Philips, President of
CTI.
【在 m*********y 的大作中提到】
: CTIC，明天开盘平开或者稍微低开无量可进。
|
|
